Intellia Therapeutics, Inc. Balance Sheet
NTLA / Health Care|12 years of annual SEC 10-K data (FY2014-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 12 fiscal years. All figures from audited SEC 10-K filings.
Intellia Therapeutics, Inc. had $842M in total assets and $671M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $155.5M | $189.2M | $226.7M | $523.5M | $123.4M | $160.0M | $57.2M | $58.9M | $340.7M | $273.1M | $75.8M | $9.8M |
| Accounts Receivable | $9.5M | $8.5M | $36.5M | $3.8M | $2.0M | $2.1M | $4.6M | $7.5M | $10.5M | $6.5M | $1.0M | - |
| Current Assets | $527.7M | $639.9M | $998.3M | $1.2B | $769.3M | $616.5M | $289.5M | $325.0M | $354.8M | $281.3M | $77.6M | - |
| PP&E (Net) | $17.7M | $27.4M | $32.8M | $27.9M | $21.0M | $15.9M | $18.0M | $17.1M | $15.3M | $10.6M | $2.7M | - |
| Total Assets | $842.1M | $1.2B | $1.3B | $1.5B | $1.3B | $676.3M | $334.3M | $347.3M | $376.2M | $299.0M | $82.1M | - |
| Current Liabilities | $103.9M | $110.9M | $115.2M | $126.6M | $125.8M | $64.3M | $35.6M | $40.6M | $31.4M | $30.7M | $10.7M | - |
| Shareholders' Equity | $671.4M | $872.0M | $1.1B | $1.2B | $1.0B | $527.1M | $269.9M | $277.9M | $300.6M | $209.8M | -$21.2M | $7.6M |